Eric T. Matey

460 total citations
12 papers, 194 citations indexed

About

Eric T. Matey is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Genetics. According to data from OpenAlex, Eric T. Matey has authored 12 papers receiving a total of 194 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Pediatrics, Perinatology and Child Health and 3 papers in Genetics. Recurrent topics in Eric T. Matey's work include Pharmacogenetics and Drug Metabolism (6 papers), Pharmaceutical studies and practices (4 papers) and Genomics and Rare Diseases (2 papers). Eric T. Matey is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Pharmaceutical studies and practices (4 papers) and Genomics and Rare Diseases (2 papers). Eric T. Matey collaborates with scholars based in United States, United Kingdom and United Arab Emirates. Eric T. Matey's co-authors include Ann M. Moyer, Virginia M. Miller, Wayne T. Nicholson, Christine M. Formea, Robert R. Freimuth, Jessica Wright, Tammy M. McAllister, Konstantinos N. Lazaridis, Jyothsna Giri and Carolyn R. Rohrer Vitek and has published in prestigious journals such as Mayo Clinic Proceedings, Neurogastroenterology & Motility and American Journal of Health-System Pharmacy.

In The Last Decade

Eric T. Matey

10 papers receiving 183 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric T. Matey United States 6 97 63 44 40 27 12 194
Emily J. Cicali United States 9 170 1.8× 99 1.6× 36 0.8× 33 0.8× 29 1.1× 28 261
Rebecca Pulk United States 7 52 0.5× 45 0.7× 30 0.7× 18 0.5× 36 1.3× 14 172
Kristin Wiisanen United States 9 162 1.7× 88 1.4× 33 0.8× 34 0.8× 29 1.1× 20 213
Lidija Konta Germany 6 133 1.4× 66 1.0× 44 1.0× 13 0.3× 35 1.3× 8 204
Anne‐Marie Buunk Netherlands 7 200 2.1× 100 1.6× 33 0.8× 19 0.5× 45 1.7× 7 303
Laura Train United States 6 136 1.4× 80 1.3× 43 1.0× 13 0.3× 66 2.4× 10 289
Catherine Chanfreau‐Coffinier United States 8 94 1.0× 65 1.0× 44 1.0× 46 1.1× 20 0.7× 31 256
Bianca Soree Netherlands 7 167 1.7× 85 1.3× 29 0.7× 16 0.4× 45 1.7× 11 272
Leland E. Hull United States 9 112 1.2× 86 1.4× 104 2.4× 46 1.1× 25 0.9× 22 284
Catherine Hajek United States 7 51 0.5× 34 0.5× 67 1.5× 28 0.7× 28 1.0× 22 160

Countries citing papers authored by Eric T. Matey

Since Specialization
Citations

This map shows the geographic impact of Eric T. Matey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric T. Matey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric T. Matey more than expected).

Fields of papers citing papers by Eric T. Matey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric T. Matey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric T. Matey. The network helps show where Eric T. Matey may publish in the future.

Co-authorship network of co-authors of Eric T. Matey

This figure shows the co-authorship network connecting the top 25 collaborators of Eric T. Matey. A scholar is included among the top collaborators of Eric T. Matey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric T. Matey. Eric T. Matey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Wright, Jessica, et al.. (2024). The potential influence of estrogen-containing oral contraception on clozapine metabolism in a patient with known pharmacogenomic status. Mental Health Clinician. 14(3). 220–223. 1 indexed citations
4.
Staab, Jeffrey P., Eric T. Matey, Jessica Wright, et al.. (2023). Most patients with disorders of gut‐brain interaction receive pharmacotherapy with major or moderate drug‐gene interactions. Neurogastroenterology & Motility. 36(2). e14722–e14722. 1 indexed citations
5.
Wright, Jessica, et al.. (2023). Pharmacists’ role in supporting the return of over 10,000 preemptive pharmacogenomics results: The Mayo Clinic experience. American Journal of Health-System Pharmacy. 80(23). 1733–1742. 2 indexed citations
6.
Matey, Eric T., Lance J. Oyen, Carolyn R. Rohrer Vitek, et al.. (2021). Nine-gene pharmacogenomics profile service: The Mayo Clinic experience. The Pharmacogenomics Journal. 22(1). 69–74. 23 indexed citations
7.
Wright, Jessica, Ann M. Moyer, Joseph Sutton, et al.. (2021). Pharmacogenomics Testing in Patients with Liver Transplant and Potential Impact on Prospective Management. Pharmacogenomics. 22(18). 1177–1183. 3 indexed citations
8.
Nicholson, Wayne T., Christine M. Formea, Eric T. Matey, et al.. (2020). Considerations When Applying Pharmacogenomics to Your Practice. Mayo Clinic Proceedings. 96(1). 218–230. 23 indexed citations
9.
Moyer, Ann M., Eric T. Matey, & Virginia M. Miller. (2019). Individualized medicine: Sex, hormones, genetics, and adverse drug reactions. Pharmacology Research & Perspectives. 7(6). e00541–e00541. 66 indexed citations
10.
Formea, Christine M., Wayne T. Nicholson, Carolyn R. Rohrer Vitek, et al.. (2018). Implementation of a pharmacogenomics education program for pharmacists. American Journal of Health-System Pharmacy. 75(23). 1939–1946. 20 indexed citations
11.
Freimuth, Robert R., et al.. (2017). Implementing Genomic Clinical Decision Support for Drug-Based Precision Medicine. CPT Pharmacometrics & Systems Pharmacology. 6(3). 153–155. 35 indexed citations
12.
Cousin, Margot A., Eric T. Matey, Patrick R. Blackburn, et al.. (2017). Pharmacogenomic findings from clinical whole exome sequencing of diagnostic odyssey patients. Molecular Genetics & Genomic Medicine. 5(3). 269–279. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026